Clinical Trial Update: Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of empagliflozin/metformin, sitagliptin/metformin, and metformin on adipokines in Type 2 diabetes; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)
• Janumet (sitagliptin/metformin)
• SYNJARDY (empagliflozin and metformin hydrochloride)

Snippet

Sponsor: Hawler Medical University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED